KUBOTA PHARMACEUTICAL HOLDINGS CO LTD Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q3 FY2014 As of Sep 30, 2014	Q2 FY2014 As of Jun 30, 2014	Q1 FY2014 As of Mar 31, 2014
Assets
Current assets:
Cash and cash equivalents
Investments
Accounts receivable from collaborations
Deferred tax asset
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Long-term investments
Long-term deferred tax asset
Deferred offering costs
Other assets
Total assets
Liabilities and shareholders’ equity
Current liabilities:
Current maturities of contingently convertible debt, related party
Accounts payable
Accrued liabilities
Accrued compensation
Deferred revenue from collaborations
Deferred rent and lease incentives
Total current liabilities
Long-term deferred rent, lease incentives, and others
Total long-term liabilities
Shareholders’ equity:
Preferred Stock, No Par Value
Common Stock, Value, Outstanding
Convertible preferred stock
Common stock, no par value, 151,358 shares authorized as of March 31, 2017 and December 31, 2016; 37,921 and 37,878 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity

Total liabilities and shareholders’ equity

Comments